For the fourth quarter of the fiscal year ending September 2026, an impairment loss on shares of an affiliated company and an equity-method investment loss were recorded as an extraordinary loss and non-operating expense. These affect the consolidated financial statements but are recorded in the separate financial statements as well; impairments have occurred and have been reflected in the published financial summary.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3672","jir_company_name":"AltPlus Holdings Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/3672-20261112-02.pdf","jir_short_summary":"For the fourth quarter of the fiscal year ending September 2026, an impairment loss on shares of an affiliated company and an equity-method investment loss were recorded as an extraordinary loss and non-operating expense. These affect the consolidated financial statements but are recorded in the separate financial statements as well; impairments have occurred and have been reflected in the published financial summary.","jir_summary":"### Recording of Extraordinary Losses and Non-operating Expenses\nIn the fourth quarter of the fiscal year ending September 2026, an impairment loss on shares of an affiliated company of 557,249 thousand yen was recorded in the separate financial statements. In the consolidated financial statements, related to this impairment, an equity-method investment loss of 533,246 thousand yen, including a one-time write-off of goodwill-equivalent amounts, was recorded as a non-operating expense. These items are reflected in the financial summary.\n\n### Impairment Treatment and Impact on Performance\nThe company also performed impairment on business assets and recorded an impairment loss of 10,270 thousand yen as an extraordinary loss. These losses affect both consolidated and separate financial reporting, and the impact on the consolidated statements is as described in the disclosure document.","jir_financial_highlights":"Impairment Loss on Shares of Affiliated Company: 557,249 thousand yen (Unknown)\nEquity-method Investment Loss (recorded as non-operating expense): 533,246 thousand yen (Unknown)\nImpairment Loss on Fixed Assets: 10,270 thousand yen (Unknown)","jir_category":"","jir_hashtags":"#AltPlusHoldings_Disclosure, #ExtraordinaryLoss_NonOperatingExpense","jir_key_figures":"Impairment loss on shares of affiliated company: 557,249 thousand yen\nEquity-method investment loss: 533,246 thousand yen\nImpairment loss on fixed assets: 10,270 thousand yen","jir_meta_title":"AltPlus Holdings Inc. \u2014 Notice of Recording Extraordinary Losses and Non-operating Expenses | Q4 FY2026","jir_meta_description":"AltPlus Holdings Inc. announced the recording of an impairment loss on affiliated company shares and an equity-method investment loss in Q4 FY2026, as well as related asset impairments, and explains the impact on consolidated and separate financial statements.","jir_og_title":"AltPlus Holdings Inc. \u2014 Notice of Recording Extraordinary Losses","jir_og_description":"Disclosure of the recording of an impairment loss on shares of an affiliated company and an equity-method investment loss for Q4 FY2026, including the execution of impairments and the impact on consolidated results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60353,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-150775","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n